COMMUNIQUÉS West-GlobeNewswire

Iron Age Nutrition Announces Launch of “Sour Apple Crush” Flavor in Total Hydrate Electrolyte Line
05/06/2026
FORT LAUDERDALE, FL, June 04, 2026 (GLOBE NEWSWIRE) -- Iron Age Nutrition announced the introduction of “Sour Apple Crush,” a new flavor within its Total Hydrate electrolyte line. The addition expands the company’s [...]
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that study results [...]
Research Peptides: Koi Research Labs Expands Distribution Across USA & Canada
05/06/2026
NEW YORK, NY, June 05, 2026 (GLOBE NEWSWIRE) -- Koi Research Labs today announced the expansion of its research-grade peptide distribution across the United States and Canada, giving qualified researchers in both [...]
Native Life Appoints FIFA Brand Designer Jody Ure to Lead Creative Strategy and Support National Expansion
05/06/2026
Miami, Florida, June 04, 2026 (GLOBE NEWSWIRE) -- Native Life, an emerging life and health insurance company operating across all 50 states, announced the appointment of globally recognized FIFA brand designer Jody Ure [...]
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04/06/2026
SOUTH SAN FRANCISCO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
CooperCompanies Announces Second Quarter 2026 Results
04/06/2026
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026. Second [...]
DLH Announces Filing of New Shelf Registration Statement
04/06/2026
ATLANTA, June 04, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04/06/2026
CONSHOHOCKEN, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
04/06/2026
Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital WILMINGTON, Del., June 04, 2026 (GLOBE NEWSWIRE [...]
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
04/06/2026
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]
Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental
04/06/2026
MINNEAPOLIS, June 04, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announces that effective May 29, 2026, Zumbro View Dental joined the Park [...]
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04/06/2026
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
Nyxoah Announces Proposed Offering of Ordinary Shares
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – June 4, 2026, 10:02 pm CET / 4:02 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 4 juin 2026, 22h02 CET / 16h02 ET – Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2026, the Company [...]
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme Lancement du processus de transition vers un Chief Executive Officer basé aux États-Unis Cette [...]
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
04/06/2026
Jilin, China, June 04, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
04/06/2026
Creation of a next-generation environmental platform: The proposed transaction brings together essential safety and environmental services, with a strategic focus on regulatory-driven industries where compliance, [...]
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
04/06/2026
Milestone achievement advances potential first FDA-approved disease-modifying therapy for pterygium, a condition affecting just under one billion people globally, including 15 million people in the U.S. Topline data [...]

Pages